Path Ex

Houston, TX · Founded 2017 · Privately Held (backing)

Developer of an extracorporeal blood-cleansing device designed for the diagnosis and treatment of sepsis. Path Ex is based in Houston, TX and was founded in 2017. It was valued at $31 million at its seed round in Apr 2025, the last priced event on record. It has raised $12.5 million across 1 recorded round; the latest was an $8.2 million early-stage round in Apr 2025.

PMV mark · valuation
$31.0M
Oct 2026
Priced at
its seed round
Apr 2025
Total raised
$12.5M
Last round
Early Stage VC
Apr 2025

Who backs Path Ex?

18 investors
InvestorType
US National Science FoundationOther
MassChallenge—
MedTech InnovatorOther
Texas Medical CenterVenture capital
Johnson & Johnson Innovation - JLABSOther
Launch TennesseeOther
IAG Capital PartnersVenture capital
Symbiotic VenturesVenture capital
Vanderbilt UniversityOther
Fitz Gate VenturesVenture capital
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Path Ex investors

18 investors are on record for Path Ex, including US National Science Foundation, MassChallenge, MedTech Innovator and Texas Medical Center. By type, the record holds 5 venture capital firms. The early-stage round in Apr 2025 drew 14 investors.

Free account
More of Path Ex with a free account
  • ·The complete investor list: 18 names
  • ·Watch Path Ex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like Path Ex. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View